McKesson Corporation (MCK) is one of the top companies in the pharma industry. It had a successful period of continuous growth, reaching an all-time stock high at $667.08 and showing robust growth. The company's quarterly dividends and increased guidance have attracted many investors. However, the company had a significant decline of 15.2% in Q3. Market volatility seems to influence the corporation's performance as its stock performance both increased and fell behind the market. Although the company missed its third-quarter revenue estimates, McKesson earned positive comments from TV personality Jim Cramer, who called it a 'Trump Stock' and recognized its resilience in face of competition. Despite some risks, shares remain a good buy for the long-term, offering considerable value. Notably, McKesson has completed the divestiture of Canada-based Rexall and Well.ca businesses and has taken a controlling interest in PRISM Vision. However, the corporation's stock declined post-divestiture.
Mckesson Corporation MCK News Analytics from Wed, 07 Aug 2024 07:00:00 GMT to Sat, 22 Mar 2025 14:57:37 GMT -
Rating 8
- Innovation 7
- Information 9
- Rumor -3
